Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pituitary Neoplasms × lanreotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroendocrine Tumors 4 Carcinoid Tumor 3 Serotonin Syndrome 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Neuroendocrine Tumour With Carcinoid Symptoms 1 Neuroendocrine Tumors in Lung 1 Gigantism 1 Gastrointestinal Neoplasms 1 Flushing 1 Endocrine Tumors 1 Diarrhea 1 Acromegaly 1

Interventions

pasireotide 4 Cabergoline 2 lanreotide 1 Thyrotropin-Releasing Hormone 1 Rosiglitazone 1 Ibuprofen 1 Hydrocortisone 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated

4 enrolled 5 charts

Acromegaly, Gigantism, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡